Title | Febrile Neutropenia [electronic resource] / edited by Jean A. Klastersky |
---|---|
Imprint | Berlin, Heidelberg : Springer Berlin Heidelberg, 1997 |
Connect to | http://dx.doi.org/10.1007/978-3-642-60443-0 |
Descript | XVI, 130p. 11 illus. online resource |
High-Dose Chemotherapy: Safer and Better? -- Bone Marow Protectors in Cancer Treatment -- Hematopoietic growth factors in febrile neutropenia โ Indications and limitations -- Incorporation of Quality-of-Life Considerations into Decisions Model for the Use of Colony-Stimulating Factors in Chemotherapy Patients at Risk for Febrile Neutropenia -- Assessing Risk in Cancer Patients with Fever and Neutropenia -- Therapeutic Approach in the Ambulatory Setting, Feasability and Surveillance -- The Sequence of Infective Events in Prolonged Neutropenia -- The Empirical Therapeutic Cascade: When to Start and When to Stop? -- Treatment of Neutropenic Infection: Trends Towards Monotherapy? -- The Changing Spectrum of Bacterial Infections in Febrile Neutropenic Patients -- Susceptibility of Streptococci Isolated from Blood of Neutropenic Patients to 11 Antibiotics -- Emerging Antibiotic Resistance in bacterial Pathogens -- Cefepime Versus Ceftazidime as Empiric Therapy of Febrile Episodes in Neutropenic Patients -- Cefepime Versus Ceftazidime in the Empiric Treatment of Febrile Neutropenic Children with Malignancy -- Cefepime-Vancomycin Versus Ceftazidime-Vancomycin as Empiric Therapy in Febrile Neutropenic Patients -- Monotherapy with Meropenem Versus Combination Therapy with Ceftazidime Plus Amikacin as Empiric Therapy for Fever in Granulocytopenic Patients with Cancer -- Piperacillin plus Tazobactam Versus Ceftazidime plus Amikacin in Febrile Neutropenia: A Comparison in Terms of Cost and Efficacy -- Fungal Infection in Neutropenic Patients: Past Achivements and Future Problems -- The Pressure of Emerging Resistance in Fungal Diseases -- Liposomal Versus Conventional Amphotericin B for the Treatment of Fever of Unknown Origin in Neutropenic Patients: Results of two Randomized Trials in 204 Children and 134 Adults -- Pulmonary Infiltrate Etiology in Leukemic Patients with Fever -- Marrow Transplantation: Current Results and Effect of Immunoglobulin Prophylaxis -- The Role of Economic Evaluation in Assessing the Cost of Febrile Neutropenia -- Quality of life in Patients with Febrile Neutropenia